183 related articles for article (PubMed ID: 29408171)
1. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
[TBL] [Abstract][Full Text] [Related]
2. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792
[TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury.
Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q
Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674
[TBL] [Abstract][Full Text] [Related]
4. The change of plasma galectin-3 concentrations after traumatic brain injury.
Shen YF; Yu WH; Dong XQ; Du Q; Yang DB; Wu GQ; Zhang ZY; Wang H; Jiang L
Clin Chim Acta; 2016 May; 456():75-80. PubMed ID: 26944570
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury.
Wu GQ; Chou XM; Ji WJ; Yang XG; Lan LX; Sheng YJ; Shen YF; Li JR; Huang GZ; Yu WH; Dong XQ; Du Q; Yang DB; Zhang ZY; Wang H; Shen YF; Jiang L
Clin Chim Acta; 2016 Jul; 458():124-8. PubMed ID: 27155585
[TBL] [Abstract][Full Text] [Related]
6. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
7. Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ
Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum translocator protein in patients with traumatic brain injury.
Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD
Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury.
Zhang ZY; Li J; Ye Q; Dong Y; Bao GM; Shen YK; Weng JF; Luo LF; Cen M
Clin Chim Acta; 2019 Oct; 497():6-12. PubMed ID: 31279693
[TBL] [Abstract][Full Text] [Related]
10. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
[TBL] [Abstract][Full Text] [Related]
11. Serum CXC chemokine ligand-12 as a potential predictor for in-hospital major adverse events after severe traumatic brain injury.
Shen LJ; Zhou J; Yang CS; Lv QW; Xu QC
Clin Chim Acta; 2020 Oct; 509():244-248. PubMed ID: 32569633
[TBL] [Abstract][Full Text] [Related]
12. Serum S100A12 and 30-day mortality after acute intracerebral hemorrhage.
Qian SQ; He SR; Li BB; Qian J; Zheng XD
Clin Chim Acta; 2018 Feb; 477():1-6. PubMed ID: 29196185
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on serum secreted protein acidic and rich in cysteine-like 1 as a prognostic marker for severe traumatic brain injury.
Huang HB; Yang SB; Shen LJ; Lv QW; Guo M; Zhou J; Li Z; Yang CS; Wang LY; Zhang H
Clin Chim Acta; 2019 Apr; 491():19-23. PubMed ID: 30639238
[TBL] [Abstract][Full Text] [Related]
14. Importance of AIM2 as a serum marker for reflecting severity and predicting a poor outcome of human severe traumatic brain injury: A prospective longitudinal cohort study.
Chen SH; Hu FL; Wang G; Liang XS; He CJ
Clin Chim Acta; 2024 Jun; 559():119691. PubMed ID: 38685373
[TBL] [Abstract][Full Text] [Related]
15. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
[TBL] [Abstract][Full Text] [Related]
16. Serum lipocalin-2 concentrations and mortality of severe traumatic brain injury.
Shen LJ; Zhou J; Guo M; Yang CS; Xu QC; Lv QW; Yang SB; Huang HB
Clin Chim Acta; 2017 Nov; 474():130-135. PubMed ID: 28943289
[TBL] [Abstract][Full Text] [Related]
17. Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis.
Zhao B; Chen Y; Sun WW; Chen WW; Ma L; Yang ZT; Huang J; Chen EZ; Fei J; Mao EQ
J Dig Dis; 2016 Jul; 17(7):475-82. PubMed ID: 27251034
[TBL] [Abstract][Full Text] [Related]
18. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of the serum biomarker heart-fatty acidic binding protein in comparison with s100b in severe traumatic brain injury.
Walder B; Robin X; Rebetez MM; Copin JC; Gasche Y; Sanchez JC; Turck N
J Neurotrauma; 2013 Oct; 30(19):1631-7. PubMed ID: 23590685
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
Tang B; Zhong Z; Qiu Z; Wu HP; Hu JY; Ma JP; Wu JP
Clin Chim Acta; 2019 Aug; 495():227-232. PubMed ID: 31009601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
